Apellis(APLS) - 2025 Q4 - Earnings Call Transcript

Apellis Pharmaceuticals (NasdaqGS:APLS) Q4 2025 Earnings call February 24, 2026 08:30 AM ET Company ParticipantsAnupam Rama - Biotechnology Equity ResearchCaroline Baumal - CMOCedric Francois - Co-Founder, CEO, and PresidentDavid Acheson - EVP of CommercialEllie Merrill - Biotechnology Equity Research AssociateEva Stroynowski - Investor Relations and Corporate Affairs Biotechnology ExecutiveJayed Momin - Biopharma Equity Research AssociateJonathan Miller - Equity Research, Biotech and PharmaceuticalsTazeen ...